Medical Device News Magazine

Organicell Appoints Harry Leider, MD, MBA as New CEO

About Medical Device News Magazine

About Medical Device News Magazine. We are a digital publication founded in 2008 located in the United States.

Advertise with Medical Device News Magazine! Join Our #1 Family of Advertisers!

We pride ourselves on being the best-kept secret when it comes to distributing your news! Our unique digital approach enables us to circulate your...

Summation

  • Leider has served on the faculty of the Johns Hopkins Carey School of Business and Harvard Medical School, and has published more than 25 articles and chapters related to patient care and organizational leadership in peer-reviewed journals and books.

Organicell Regenerative Medicine, Inc. (OTCQB:OCEL), a South Florida-based clinical-stage biopharmaceutical company focused on the development of innovative biological regenerative therapeutics, is pleased to announce that it has tapped Harry L. Leider, MD, MBA as its new CEO.

Dr. Harry Leider brings more than 25 years of experience as a healthcare executive and entrepreneur, with extensive experience serving in C-suite roles in both publicly-held and early-stage companies, to the position. He has advanced breakthroughs in patient care across multiple sectors of the health care industry.

Prior to joining Organicell, Dr. Leider served as the chief medical officer and executive vice president of Gelesis, a biotech company specializing in therapies for obesity. Under his leadership, the company successfully completed the process to gain FDA approval for its lead product, Plenity®; and then successfully commercialized Plenity via a unique direct-to-consumer model supported by a national telemedicine program. Furthermore, he played a key role as part of a small leadership team that led the company through its initial public offering on the New York Stock Exchange (NYSE).

Before that time, Dr. Leider served as chief medical officer and group vice president for Walgreens Boots Alliance, a Fortune 50 company where he provided leadership for all clinical programs, quality assessment activities, health outcomes research, and health analytics projects. Prior to Walgreens, he served as chief medical officer and executive vice president at Ameritox, a specialty laboratory company that enabled physicians to more safely treat patients suffering with chronic pain. He has also participated on the Board of Directors of Alivio Therapeutics, TytoCare, and Mobile Help.

During his career, Dr. Leider has served on the faculty of the Johns Hopkins Carey School of Business and Harvard Medical School, and has published more than 25 articles and chapters related to patient care and organizational leadership in peer-reviewed journals and books. He also was a core faculty member of the American Association of Physician Leadership for more than 20 years and has published five patents in the field of laboratory medicine.

“Harry brings an extensive track record of successfully launching innovative therapeutics and services that have positively impacted the practice of medicine. I am honored and excited to welcome him to our seasoned leadership team,” said Ian Bothwell, chief financial officer of Organicell. “Harry’s research and commercial expertise, along with his broad strategic business perspective, will enable Organicell to rapidly advance its successful research and commercial programs while transforming the regenerative medicine space.”

Dr. Leider stated, “I am honored to lead Organicell and work alongside a highly talented team of executives, researchers, and business associates. Together, we have a truly unique opportunity to develop and commercialize an entirely new class of therapies for important clinical conditions, while building a word-class biotherapeutic company.”

Medical Device News Magazinehttps://infomeddnews.com
Medical Device News Magazine provides breaking medical device / biotechnology news. Our subscribers include medical specialists, device industry executives, investors, and other allied health professionals, as well as patients who are interested in researching various medical devices. We hope you find value in our easy-to-read publication and its overall objectives! Medical Device News Magazine is a division of PTM Healthcare Marketing, Inc. Pauline T. Mayer is the managing editor.

Other News

HeartFlow Introduces Next Generation Interactive Plaque Analysis Platform to Assess Patient Risk in Suspected Coronary Artery Disease

The HeartFlow Plaque Analysis uses proprietary algorithms to analyze coronary CT angiogram (CCTA) scans, creating a personalized 3D model that quantifies and characterizes plaque volume in the coronary arteries, aiding risk assessment of coronary artery disease. The technology was introduced at the Society of Cardiovascular Computed Tomography (SCCT) Annual Scientific Meeting in Washington, D.C.

Ultrahuman Announces its App Store ‘PowerPlugs’ with the World’s First AFib Detection Technology on a Smart Ring

Recognizing each individual’s health journey is unique, PowerPlugs enable people to choose and focus on the aspects of their health that matter most. It’s designed for highly personalized health insights, ensuring that every individual can personalize their health tracking to their unique needs and goals.

VisionAir Solutions Celebrates Milestone and New Collaboration

This achievement marks VisionAir Solutions commitment to bringing technological innovation to pulmonary medicine. Since its acquisition by Theken Companies last year, VAS has over doubled its growth and continues to demonstrate industry adoption and the advantages of personalized healthcare.